Inspire Medical Systems, Inc. to Present at the Goldman Sachs Healthcare CEO Conference 2022

Rhea-AI Summary

Inspire Medical Systems, a medical technology firm focused on obstructive sleep apnea solutions, announced its presentation at the Goldman Sachs Healthcare CEO Conference on January 6, 2022, at 3:00 p.m. ET. The event will be live-streamed, and a replay will be available for two weeks on their investor website. Inspire is known for its FDA-approved neurostimulation technology, which provides effective treatment for moderate to severe sleep apnea. For details, visit their investor page.

News Market Reaction – INSP

-2.24%

-2.24% Session move

In the trading session that priced this news, INSP declined 2.24%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Goldman Sachs Healthcare CEO Conference on Thursday, January 6, 2022.

Inspire is scheduled to present at 3:00 p.m. Eastern Time. The presentation will be accessible via a live webcast at:
https://kvgo.com/healthcare-ceos-2022/inspire-medical-systems-inc-jan

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com 
646-597-6989

FAQ

When is Inspire Medical Systems presenting at the Goldman Sachs Healthcare CEO Conference?

Inspire Medical Systems will present on January 6, 2022, at 3:00 p.m. Eastern Time.

How can I access the Inspire Medical Systems conference presentation?

The presentation will be accessible via a live webcast at their website during the event.

How long will the Inspire Medical Systems presentation be available for replay?

The webcast replay of the presentation will be available for two weeks following the event.

What is the focus of Inspire Medical Systems?

Inspire Medical Systems focuses on innovative and minimally invasive solutions for obstructive sleep apnea.

What is the significance of Inspire's therapy?

Inspire's therapy is the first FDA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea.